Hazer Group (ASX:HZR) has completed its commercial demonstration plant and reactor test program, marking a step in the company's technological advancements. The achievement is expected to ...
CardieX (ASX:CDX) has launched its CONNEQT Pulse and CONNEQT App in the United States. The Pulse, touted as the world’s most advanced personal arterial health monitor, has begun delivery to US ...
Recce Pharmaceuticals (ASX:RCE) has dosed all 30 patients in its Phase 2 clinical trial assessing the efficacy of RECCE 327 topical gel for the treatment of acute bacterial skin and skin structure ...
GenusPlus Group (ASX:GNP), a provider of essential power and communications infrastructure, has secured a contract with Western Power for the Clean Energy Link – North Region Project. The initiative ...
The Bank of England plans to launch the Digital Pound Lab in 2025 as part of its Central Bank Digital Currency (CBDC) design phase. Collaboration with HM Treasury and global experts focuses on privacy ...
In a strategic move reshaping its vaccine operations, WuXi Biologics announced on Monday that its subsidiary, WuXi Vaccines Ireland, has entered into an agreement with Merck & Co. (NYSE:MRK) to sell ...
Qantas Airways (ASX:QAN) has fallen behind its global counterparts in the latest on-time performance rankings, according to aviation analytics firm Cirium. The analysis revealed that only 73.8% of ...
British pharmaceutical giant GSK (NYSE:GSK) is reportedly in advanced talks to acquire IDRx, a privately-held biotechnology company focused on developing treatments for a rare type of tumor. According ...
Eliza Labs, the developer behind ai16z (CRYPTO:AI16Z), has released a white paper detailing its vision for Web3-native artificial intelligence agents. The document outlines the capabilities of Eliza, ...
Artemis Resources (ASX:ARV) has appointed Julian Hanna as Managing Director, effective immediately. Hanna, a seasoned geologist and mining executive with extensive industry experience, has been ...
Neurizon Therapeutics (ASX:NUZ), a clinical-stage biotechnology company focused on neurodegenerative disease treatments, announced that the US Food and Drug Administration has placed a clinical hold ...